Glioblastoma study discovers protective role of metabolic enzyme, revealing a novel therapeutic target
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
RET Fusion Inhibitor Active Beyond Lung, Thyroid Cancers
medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.
Smoking marijuana has numerous health benefits and they are:
A lot of people say cannabis has no medicinal value when it is smoked. Let’s finally put this myth to bed. Is smoking weed good for you? Well…. It depends…
1. Cancer
There are a lot of people that say smoking pot can cause lung cancer because your inhaling smoke, like cigarettes. This simply isn’t true. Cigarette smoke causes cancer because the tobacco is radiated whereas marijuana isn’t. In fact, the American Association for Cancer Research has found the marijuana actually works to slow down tumor growth in the lungs, breasts, and brain considerably. http://www.sciencedaily.com/releases/2007/04/070417193338.htm
LAVA Therapeutics Provides Business Update and Reports First Quarter Financial Results
IPO bolsters balance sheet to $160 million in cash and cash equivalents; expected to fund operations at least into the second half of 2023
Clinical development plans on schedule in both hematological and solid tumor programs
Leadership strengthened through key management and board appointments
UTRECHT, The Netherlands and PHILADELPHIA, May 20, 2021 (GLOBE NEWSWIRE) LAVA Therapeutics N.V. (Nasdaq: LVTX), a biotechnology company focused on applying its expertise in gamma-delta bispecific T cell engagers (bsTCEs) to transform cancer therapy, today reported its business update and first quarter 2021 financial results.
“We continue to make important strides across all aspects of our business as we transition to a clinical stage organization,” said Stephen Hurly, chief executive officer of LAVA Therapeutics. “With the recent additions to our leadership team and board and the proceeds from